Assessing effectiveness of adding niosomal atorvastatin 1% ointment to topical calcineurin inhibitor treatment in non‐segmental vitiligo
Journal of Cosmetic Dermatology · 2024
DOI: 10.1111/jocd.16227 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von Hamed Zartab und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Vitiligo, Atorvastatin, Tacrolimus, Calcineurin Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Treatment of vitiligo is still a big challenge for dermatologists. The efficacy of statins in the treatment of vitiligo is controversial. Aim and Objective We studied possible therapeutic effect of topical 1% niosomal atorvastatin ointment combined with topical 0.1% tacrolimus in treatment of non‐segmental vitiligo.
Methods
This is a triple blind, pilot, randomized placebo‐controlled trial (RCT) that was performed in dermatology clinic. All the patients used topical 0.1% tacrolimus cream twice daily (BD). Moreover, the intervention group participants used topical 1% niosomal atorvastatin ointment, and control group participants were prescribed placebo ointment, BD. Patients were evaluated using vitiligo area surface index (VASI) score and patients' satisfaction at baseline and after 3 months treatment.
Results
The mean patient satisfaction in the intervention and control groups were 5 ± 1.4 and 3.5 ± 1.9; the difference between groups was not statistically significant ( p = 0.9). We found statistically significant difference in VASI score before and after treatment in both intervention and control groups ( p = 0.01 and p = 0.03, respectively). However, comparison of the VASI score between groups was not statistically significant ( p = 0.62). We also found no significant correlation between VASI score and other variables.
Conclusion
The result of this study indicates that adding of niosomal atorvastatin 1% ointment to topical calcineurin inhibitor has no additional effect on non‐segmental type of vitiligo. Further large studies with different combinations are recommended before any conclusive result can be concluded on efficacy of statins in vitiligo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.
- Taleghani Hospital, Urmia University of Medical Sciences, Urmia, Iran.
- Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran.
- Pathology and Stem Cells Research Center, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
- Neuropharmacology Institute, Pharmaceutics Research Center, Kerman University of Medical Sciences, Kerman, Iran.
- Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Mahin Aflatoonian
Zitieren
APA
Zartab, H., Aflatoonian, M., Shamsi-Meymandi, S., Pardakhty, A., Isazadeh, A., Firooz, A., & Amiri, R. (2024). Assessing effectiveness of adding niosomal atorvastatin 1% ointment to topical calcineurin inhibitor treatment in non‐segmental vitiligo. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16227
Vancouver
Zartab H, Aflatoonian M, Shamsi-Meymandi S, Pardakhty A, Isazadeh A, Firooz A, et al. Assessing effectiveness of adding niosomal atorvastatin 1% ointment to topical calcineurin inhibitor treatment in non‐segmental vitiligo. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16227
BibTeX
@article{Zartab2024,
author = {Zartab, Hamed and Aflatoonian, Mahin and Shamsi-Meymandi, Simin and Pardakhty, Abbas and Isazadeh, Ahdie and Firooz, Alireza and Amiri, Rezvan},
title = {Assessing effectiveness of adding niosomal atorvastatin 1% ointment to topical calcineurin inhibitor treatment in non‐segmental vitiligo},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
doi = {10.1111/jocd.16227}
}
EUVIMED